v3.24.3
Company's Stockholders' Equity (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Nov. 02, 2024
Aug. 03, 2024
May 04, 2024
Oct. 28, 2023
Jul. 29, 2023
Apr. 29, 2023
Nov. 02, 2024
Oct. 28, 2023
Balance at beginning of period $ 1,070,337 $ 1,031,426 $ 996,932 $ 825,859 $ 801,474 $ 794,905 $ 996,932 $ 794,905
Net income 90,597 73,760 78,514 48,551 30,892 32,748 $ 242,871 $ 112,191
Stock options exercised 4,707 15,393 8,472 1,105 1,512 10,764    
Stock options exercised (in shares) [1]             172,168  
Shares used for tax withholding (601) (916) (12,222) (537) (8,626) (1,962)    
Shares purchased as part of publicly announced program $ (56,382) (61,721) (63,769) $ (52,379) (26,104) (51,823)    
Vesting of restricted shares 637,000     95,000     485,000 172,000
Stock based compensation $ 25,410 24,779 19,107 $ 21,645 19,425 16,722    
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit 15,895 (9,037) 7,735 7,618 8,465 947 $ 14,593 $ 17,029
Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes (3,476) (3,347) (3,343) (1,386) (1,179) (827) (10,166) (3,391)
Balance at end of period 1,146,487 1,070,337 1,031,426 850,476 825,859 801,474 1,146,487 850,476
Common Stock                
Balance at beginning of period $ 8 $ 8 $ 8 $ 8 $ 8 $ 8 $ 8 $ 8
Balance at beginning of period (in shares) 82,746,507 82,636,872 82,399,577 82,326,476 82,157,501 82,037,994 82,399,577 82,037,994
Stock options exercised (in shares) 26,519 89,961 55,688 8,101 15,236 90,971    
Vesting of restricted shares 8,063 19,674 181,607 19,714 153,739 28,536    
Balance at end of period $ 8 $ 8 $ 8 $ 8 $ 8 $ 8 $ 8 $ 8
Balance at end of period (in shares) 82,781,089 82,746,507 82,636,872 82,354,291 82,326,476 82,157,501 82,781,089 82,354,291
Additional Paid-in Capital                
Balance at beginning of period $ 2,186,107 $ 2,145,935 $ 2,118,356 $ 2,064,048 $ 2,043,111 $ 2,015,625 $ 2,118,356 $ 2,015,625
Stock options exercised 4,707 15,393 8,472 1,105 1,512 10,764    
Stock based compensation 25,410 24,779 19,107 21,645 19,425 16,722    
Balance at end of period 2,216,224 2,186,107 2,145,935 2,086,798 2,064,048 2,043,111 2,216,224 2,086,798
Accumulated Earnings                
Balance at beginning of period 1,136,338 1,062,578 984,064 708,055 677,163 644,415 984,064 644,415
Net income 90,597 73,760 78,514 48,551 30,892 32,748    
Balance at end of period 1,226,935 1,136,338 1,062,578 756,606 708,055 677,163 1,226,935 756,606
Accumulated Other Comprehensive Income                
Balance at beginning of period 25,541 37,925 33,533 36,154 28,868 28,748 33,533 28,748
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit 15,895 (9,037) 7,735 7,618 8,465 947    
Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes (3,476) (3,347) (3,343) (1,386) (1,179) (827)    
Balance at end of period 37,960 25,541 37,925 42,386 36,154 28,868 37,960 42,386
Treasury Stock                
Balance at beginning of period $ (2,277,657) $ (2,215,020) $ (2,139,029) $ (1,982,406) $ (1,947,676) $ (1,893,891) $ (2,139,029) $ (1,893,891)
Balance at beginning of period (in shares) (19,084,149) (18,810,851) (18,435,206) (17,476,448) (17,273,152) (17,018,281) (18,435,206) (17,018,281)
Shares used for tax withholding $ (601) $ (916) $ (12,222) $ (537) $ (8,626) $ (1,962) $ (13,700)  
Shares used for tax withholding (in shares) (2,564) (3,790) (63,407) (3,633) (48,938) (9,457) (69,761)  
Shares purchased as part of publicly announced program $ (56,382) $ (61,721) $ (63,769) $ (52,379) $ (26,104) $ (51,823)    
Shares purchased as part of publicly announced program, (in shares) (213,372) (269,508) (312,238) (348,948) (154,358) (245,414)    
Balance at end of period $ (2,334,640) $ (2,277,657) $ (2,215,020) $ (2,035,322) $ (1,982,406) $ (1,947,676) $ (2,334,640) $ (2,035,322)
Balance at end of period (in shares) (19,300,085) (19,084,149) (18,810,851) (17,829,029) (17,476,448) (17,273,152) (19,300,085) (17,829,029)
[1] Options exercised during the nine month period ended November 2, 2024 had a total intrinsic value of $12.0 million.